Abstract
One of the most intensively studied non-genotoxic carcinogens is the phorbol ester tumor promoter 12-0-tetradecanoylphorbol-13-acetate (TPA). Since TPA appears to exert its biologic effects through protein kinase C (PKC), a key enzyme in signal transduction, we have studied this enzyme in considerable detail. To explore the role of PKC in carcinogenesis we developed various types of cell lines that overproduce the PKC βI isoform. To gain further insight into the relationship between PKC structure and its function in tumor promotion we expressed deletion mutants of PKC βI in a rat fibroblast cell line. These studies provide genetic evidence that PKC plays a critical role in growth control and the action of certain growth factors, tumor promoters and oncogenes. The findings are discussed within the context of multistage carcinogenesis, risk assessment, and cancer prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ames, B.N. and Gold, L.S., 1990, Too many rodent carcinogens: mitogenesis increases mutagenesis, Science, 249:970–971.
Anderson, W.B., Estival, A., Tapiovaara, H., and Gopoalakrishna, R., 1985, Altered subcellular distribution of protein kinase C (a phorbol ester receptor): Possible role in tumor promotion and the regulation of cell growth, Adv. Cycl. Nucl. Res., 19: 287–306.
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P., and Karin, M., 1987, Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor, Cell, 49:729–731.
Ashby, J., and Tennant, R.W., 1988, Summary of tumorigenicity data for 222 chemicals evaluated by the United States National Toxicology Program: Correlations of chemical structure, mutagenicity to salmonella and tumor sites, Mutation Res., 204:17–115.
Ashendel, C.L., and Minor, P.L., 1986, Mechanism of phorbol ester activation of calcium activated phospholipid-dependent protein kinase. Carcinogenesis, 7:517–521.
Bacher, N., Zisman, Y., Berant, E., Livneh, E., 1991, Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin and heart, Molec. and Cell. Biol., 11:126–133.
Ballester, R. and Rosen, O.M., 1985, Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate, J. Biol. Chem., 260: 15194–15199.
Balmain, A. and Pragnell, I.B., 1983, Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene, Nature, 303:72–74.
Balmain, A., Ramsden, M., Bowden, G.T., and Smith, J., 1984, Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas, Nature, 307:658–660.
Bar-Sagi, D. and Feramisco, J.R., 1988, Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation, Cell, 42:841–848.
Berenblum, I., 1982, Sequential aspects of chemical carcinogenesis: skin. In: “Cancer: A Comprehensive Treatise,” Vol. 1, Ed. 2., F.F. Becker, ed., Plenum Publishing Corp, New York.
Bernards, R., 1991, N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma, EMBO J., 10:1119–1125.
Bishop, J.M., 1991, Molecular themes in oncogenesis, Cell, 64:235–248.
Bohmann, D., Bos, T.J., Adman, A., Nishimura, T., Vogt, P.K., and Tjian, R., 1987, Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1, Science, 238:1386–1391.
Borner, C., Eppenberger, U., Wyss, R., and Fabbro, D., 1988, Continuous synthesis of two protein kinase C-related proteins after down-regulation by phorbol esters, Proc. Natl. Acad. Sci. USA., 85:2110–2114.
Borner, C., Nichols-Guadagno, S., Hseih, L.L., Hsiao, W.-L.W., and Weinstein I.B., 1990, Transformation by a ras oncogene causes increased expression of PKCα and decreased expression of PKC∈, Cell Growth and Differ., 1:653–660.
Burns, D.J., Bloomenthal, J., Lee, M.H., and Bell, R.M., 1990, Expression of the α, βII, and γ protein kinase C isozymes in the baculovirus-insect cell expression system, J. Biol. Chem., 265:12044–12051.
Burns, D.J. and Bell, R.M., 1991, Protein kinase C contains two phorbol ester binding domains, J. Biol. Chem., 266:18330–18338.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., Nishizuka, Y., 1982, Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters, J. Biol. Chem., 257:7847–7854.
Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S., 1991, Oncogenes and signal transduction. Cell, 64:281–302.
Chiu, R., Boyle, W.J., Meek, J., Smeal, T., Hunter, T., and Karin, M., 1988, The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes, Cell, 54:541–547
Choi, P.M., Tchou-Wong, K.-M., and Weinstein, I.B., 1990, Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression, Molec. and Cell. Biol., 10:4650–4657.
Coussens, L., Rhee, L., Parker, P.J., and Ullrich, A., 1987, Alternative splicing in-creases the diversity of the human protein kinase C family, DNA, 6:389–394.
Diamond, L., 1987, Tumor promoters and cell transformation, In: “Mechanisms of Cellular Transformation by Carcinogenic Agents” (pp 73–133), D. Grunberger and S.P. Goff, eds., Pergamon Press, New York.
Farago, A., and Nishizuka, Y., 1990, Protein kinase C in transmembrane signalling, FEBS Lett., 268:350–354.
Fearon, E.R., Cho, K.R., Nigro, J.M., Kern, S.E., Simons, J.W., Ruppert, J.M., Hamilton, S.R., Preisinger, A.C., Thomas, G., Kinzler, K.W., and Vogelstein, B., 1990, Identification of a chromosome 18q gene that is altered in colorectal cancers, Science, 247:49–56.
Fitzer, C.J., O’Brian, C.A., Guillem, J.G., and Weinstein, I.B., 1987, The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several related bile acids, Carcinogenesis, 8:217–220.
Fleischmann, L.F., Cuahwala, S.B., and Cantley, L., 1986, ras-transformed cells: altered levels of phosphatidylinositol 4,5 bisphosphate and catabolites, Science, 231: 407–410.
Fournier, A., and Murray, A.W., 1987, Application of phorbol ester to mouse skin causes a rapid and sustained loss of protein kinase C, Nature, 330:767–769.
Friedman, E., Isaksson, P., Rafter, J., Marian, B., Winawer, S., and Newmark, H., 1989, Fecal diglycerides as selective endogenous mitogens for premalignant and malignant human colonic epithelial cells, Cancer Research, 49:544–548.
Guillem, J.G., Levy, M.F., Hsieh, L.L., Johnson, M.D., LoGerfo, P., Forde, K.A. and Weinstein, I.B., 1990, Increased levels of phorbin, c-myc and ornithine decarboxylase in human colon cancer, Molec. Carcinogenesis, 3:68–74.
Guillem, J.G., O’Brian, C.A., Fitzer, C.J., Forde, K.A., LoGerfo, P., Treat, M., and Weinstein, I.B., 1987, Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas, Cancer Research, 47:2036–2039.
Hashimoto, K., Kishimoto, A., Hiroaki, A., Yasuda, I., Mikawa, K., and Nishizuka, Y., 1990, Protein kinase C during differentiation of human promyelocytic leukemia cell line HL-60, FEBS Lett. 263:31–34.
Hata, A., Akita, Y., Konno, Y., Suzuki, K., and Ohno, S., 1989, Direct evidence that the kinase activity of protein kinase C is involved in transcriptional activation through a TPA-responsive element, FEBS Lett., 252:144–146.
Holliday, R., 1990, DNA methylation and epigenetic inheritance, Phil. Trans. Roy. Soc. Lond., 326:329–338.
House, C., and Kemp, B.E. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238:1726–1728 (1987).
Housey, G.M., O’Brian, C.A., Johnson, M.D., Kirschmeier, P.T., and Weinstein, I.B., 1987, Isolation of cDNA clones encoding protein kinase C: Evidence for a novel protein kinase C-related gene family, Proc. Natl. Acad. Sci. USA, 84:1065–1069.
Housey, G.M., Johnson, M.D., Hsiao, W.-L., O’Brian, C.A., Murphy, J.P., Kirschmeier, P. and Weinstein, I.B., 1988, Overproduction of protein kinase C causes disordered growth control in rat fibroblasts, Cell, 52:343–354.
Hsiao, W.-L.W., Housey, G.M., Johnson, M.D. and Weinstein, I.B., 1989, Cells that overproduce protein kinase C are hypersensitive to transformation by an activated H-ras oncogene, Molec. and Cell. Biol., 9:2641–2647.
Hsieh, L.L., Hoshina, G. and Weinstein, I.B., 1989, Phenotypic effects of overexpression of PKC βI in rat liver epithelial cells, J. Cell. Biochem., 41:179–188.
Huang, M., Chida, K., Kamata, N., Nose, K., Kato, M., Homma, M.Y., Takenawa, T., and Kuroki, T., 1988a, Enhancement of inositol phospolipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts, J. Biol. Chem., 263:17975–17980.
Huang, K.P., Huang, F.L., Nakabayashi, H., and Yoshida, Y., 1988b, Biochemical characterization of rat brain protein kinase C isozymes, J. Biol. Chem., 263:14839–14845.
Hunter, T., 1991, Cooperation between oncogenes, Cell, 64:249–270.
Hyatt, S.L., Klauck, T., and Jaken, S., 1990, Protein kinase C is localized in focal contacts of normal but not transformed fibroblasts, Molec. Carcinogenesis, 3:45–53.
Jeffreys, A.M., 1987, DNA modification by chemical carcinogens. In: “Mechanisms of Cellular Transformation by Carcinogenic Agents,” (pp 33–71), D. Grunberger and S.P. Goff, eds., Pergamon Press, New York.
Johnson, M.D., Housey, G.M., Kirschmeier, P.T., and Weinstein, I.B., 1987, Molecular cloning of gene sequences regulated by tumor promoters and mitogens through protein kinase C, Molec. and Cell. Biol., 7:2821–2829.
Joslyn, G., Carlson, M., Thliveris, A., Albertsoen, H., Gelbert, L., Samowitz, W., Groden, J., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E., Burt, R., Hughes, J.P., Warrington, J., McPherson, J., Wasmuth, J., LePaslier, D., Aderrahim, H., Cohen, D., Leppert, M., and White, R., 1991, Identification of deletion mutations and three new genes at the familial polyposis locus, Cell, 66:601–613.
Kahn, S.M., Jiang, W., Borner, C., O’Driscoll, K., and Weinstein, I.B., 1990, Construction of defined deletion mutants by thermal cycled fusion: applications to protein kinase C, Technique, 2:27–30.
Kaibuchi, K., Fukumoto, Y., Oku, N., Takai, Y., Arai, K., and Muramatsu, M., 1989, Molecular genetic analysis of the regulatory and catalytic domains of protein kinase C, J. Biol. Chem., 264:13489–13496.
Kishimoto, A., Kajikawa, N., Shiota, M., and Nishizuka, Y., 1983, Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J. Biol. Chem., 258:1156–1164.
Kishimoto, A., Mikawa, K., Hashimoto, K., Yasuda, I., Tanaka, S., Tominaga, M., Kuroda, T., and Nishizuka, Y., 1989, Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (Calpain), J. Biol. Chem., 264:4088–4092.
Kiley, A., Schaap, D., Parker, P., Hsieh, L.L., and Jaken, S., 1990, Protein kinase C heterogeneity in GH4Cl rat pituitary cells, J. Biol. Chem., 265:15704–15712.
Kinzler, K.W., Nilbert, M.C., Vogelstein, B., Bryan, T.M., Levy, D.B., Smith, K.J., Preisinger, A.C., Hamilton, S.R., Hedge, P., Markham, A., Carlson, M., Joslyn, G., Groden, J., White, R., Miki, Y., Miyoshi, Y., Nishisho, I., and Nakamura, Y., 1991, Identification of a gene located at chromosome 5g21 that is mutated in colorectal cancers, Science, 251:1366–1370.
Kirschmeier, P.T., Housey, G.M., Johnson, M.D., Perkins, A.S. and Weinstein, I.B., 1988, Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences, DNA, 7:219–225.
Klein, G., 1987, The approaching era of the tumor suppressor genes, Science, 238:1539–1546.
Knopf, J., Lee, M.-H., Sultzman, L.A., Kriz, R.W., Loomis, C.R., Hewick, R.M., and Bell, R.M., 1986, Cloning and expression of multiple protein kinase C cDNAs, Cell, 46:491–502.
Kraft, A.S. and Anderson, W.B., 1983, Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane, Nature, 301:621–623.
Krauss, R.S., Housey, G.M., Johnson, M.D., and Weinstein, I.B., 1989. Disturbances in growth control and gene expression in a C3H–10T1/2 cell line that stably overproduces protein kinase C, Oncogene, 4:991–998.
Krauss, R.S., Guadagno, S.N., Weinstein, I.B. Novel revertants of H-ras oncogene-transformed R6–PKC3 cells, manuscript submitted.
Lacal, J.C., Moscat, J., and Aaronson, S.A., 1987a, Novel source of 1,2-diacylglycerol in cells transformed by a Ha-ras oncogene, Nature, 330:259–272.
Lacal, J.C., Flemming, T.P., Warren, B.S., Blumberg, P.M. and S.A. Aaronson, S.A., 1987b, Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product, Molec. and Cell. Biol., 7:4146–4151.
Lee, W., Mitchell, P. and Tjian, R., 1987, Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements, Cell, 49:741–747.
Levy, M.F., Pocsidio, J., Guillem, J.G., Forde, K., LoGerfo, P., and Weinstein, I.B., Decreased levels of protein kinase C enzyme activity and PKC mRNA in primary human colon tumors, manuscript in preparation.
Makowske, M., Ballester, R., Cayre, Y. and Rosen, O.M., 1988, Immunochemical evidence that three protein kinase C isozymes increase in abundance during HL-60 differentiation induced by dimethyl sulfoxide and retinoic acid, J. Biol. Chem., 263:3402–3410.
Makowske, M. and Rosen O.M., 1989, Complete activation of protein kinase C by an antipeptide antibody directed against the pseudosubstrate prototope, J. Biol. Chem., 264:16155–16159.
Marais, R.M., Nguyen, O., Woodgett, J.R., and Parker, P.J., 1990, Studies on the primary sequence requirements for PKC-α,-βI and-γ peptide substrates, FEBS Lett., 277:151–155.
Melloni, E., S. Pontremeli, M. Michetti, O. Sacco, B. Sparatore, and Horecker, B.L., 1986, The involvement of calpain in the activation of protein kinase C in neutrophile stimulated by phorbol myristic acid, J. Biol. Chem., 261: 4101–4104.
Morotomi, M., Guillem, J.G., LoGerfo, P., and Weinstein, I.B., 1990, Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora, Cancer Research, 50:3595–3599.
Muramatsu, M.A., Kaibuchi, K., and Arai, K.I., 1989, A protein kinase C cDNA without the regulatory domain is active after transfection in vivo in the absence of phorbol ester, Molec. and Cell. Biol. 9:831–836.
Nair, P.P., 1988, Role of bile acids and neutral steroids in carcinogenesis, Am. J. Clin. Nutr., 48:768–774.
Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, Baba, S., Hedge, P., Markham, A., Krush, A.J., Peterson, G., Hamilton, S.R., Nilbert, M.C., Levy, D.B., Bryan, T.M., Preisinger, A.C., Smith, K.J., Su, L.-K., Kinzler, K.W., and Vogelstein, B., 1991, Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients, Science, 253:665–669.
Nishizuka, Y., 1988, The molecular heterogeneity of protein kinase C and its implications for cellular regulation, Nature, 334:661–665.
Noda, M., Ko, M., Ogura, A., Liu, D., Amano, T., Takano, T., and Ikawa, Y., (1985), Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line, Nature, 318:73–75.
Nowell, P.C., 1986, Mechanisms of tumor progression, Cancer Research, 46:2203–2207.O’Driscoll, K.R., Kahn, S.M., Borner, C.B., Jiang, W., Fabrick, K.C., and Weinstein, I.B. Stable expression and phenotypic analyses of regulatory domain mutants of protein kinase C βI in rat fibroblasts, manuscript in preparation.
Ohno, S., Akita, Y., Konno, Y., Imajoh, S., and Suzuki, K., 1988, A novel phorbol ester receptor/protein kinase, nPKC distantly related to the protein kinase C family, Cell, 53:731–737.
Ono, Y., Kurokawa, T., Fujii, T., Kawahara, K., Igarashi, K., Kikkawa, U., Ogita, K., and Nishizuka, Y., 1986, Two types of complementary DNAs of rat brain protein kinase C, FEBS Lett., 206:347–352.
Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K., and Nishizuka, Y., 1988, The structure, expression, and properties of additional members of the protein kinase C family, J. Biol. Chem., 263:6927–6932.
Ono, Y., Fujii, T., Igarashi, K., Kuno, T., Tanaka, C., Kikkawa, U., and Nishizuka, Y., 1989, Phorbol ester binding to protein kinase C requires a cysteine-rich, zincfinger-like sequence, Proc. Natl. Acad. Sci. USA., 86:4868–4871.
Osada, S., Mizuno, K., Saido, T.C., Akita, Y., Suzuki, K., Kuroki, T., and Ohno, S., 1990, A phorbol ester receptor/protein kinase, nPKCη, a new member of the protein kinase C family predominantly expressed in lung and skin, J. Biol. chem., 265:22434–22440.
Parker, P.J., Coussens, L., Totty, N., Rhee, L., Young, S., Chen, E., Stabel, S., Waterfield, M.D., and Ullrich A., 1986, The complete primary sequence of protein kinase C- The major phorbol ester receptor, Science, 233:853–859.
Pears, C.J., Kour, G., House, C., Kemp, B.E., and Parker, P.J., 1990, Mutagenesis of the pseudosubstrate site of protein kinase C leads to activation, Eur. J. Biochem, 194:89–94.
Perera, F.P., 1987, Molecular cancer epidemiology: a new tool in cancer prevention, J. Natl. Cancer Int., 78:887–898.
Pfeffer, L.M., Strulovici, B., and Saltiel, A.R., 1990, Interferon-a selectively activates the β isoform of protein kinase C through phosphatidyl choline hydrolysis, Proc. Natl. Acad. Sci. USA., 87:6537–6541.
Price, B.D., Morris, J.D.H., Marshall, C.J. and Hall, A., 1989, Stimulation of phosphatidyl choline hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation, J. Biol. Chem., 264: 16638–16643.
Priess, J., Loumis, C.R., Bishop, W.R., Stein, R., Niedel, J.E., and Bell, R.M., 1986, Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras-and sis-transformed normal rat kidney cells, J. Biol. Chem., 261: 8597–8600.
Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A., 1983, Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis, Nature, 322:78–80.
Rauscher, F.J., Cohen, D.R., Curran, T., Bos, T.J., Vogt, P.K., Bohmann, D., Tjian, R., and B.R. Franza, 1988, Fos-associated protein p39 is the product of the jun proto-oncogene, Science, 240:1010–1017.
Rodriguez-Pena, A. and Rozengurt, E., 1984, Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells, Biochem. Biophys. Res. Comm., 120:1053–1059.
Rovera, G., Santoli, D., and Damsky, C., 1979, Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester, Proc. Natl. Acad. Sci. USA., 76:2779–2783.
Santella, R.M., 1988, Application of new techniques for the detection of carcinogen adducts to human population monitoring, Mutation Research, 202:271–282.
Sassone-Corsi, P., Lamph, W.W., Kamps, M., and Verma, I.M., 1988, Fos-associated cellular p39 is related to nuclear transcription factor AP-1, Cell, 54:553–560.
Schapp, D., Parker, P.J., Bristol, A., Kriz, R., and Knopf, J., 1989, Unique substrate specificity and regulatory properties of PKCE: A rationale for diversity, FEBS Lett., 243:351–357.
Schaap, D., Hsuan, J., Totty, N., and Parker, P.J., 1990, Proteolytic activation of protein kinase C-∈, Eur. J. Biochem., 191:431–435.
Solomon, D.H., O’Driscoll, K.R., Sosne, G., Weinstein, I.B., and Cayre, Y., 1991, lα,25-Dihydroxyvitamin D3-induced regulation of protein kinase C gene expression during HL-60 cell differentiation, Cell Growth and Differ., 2:187–194.
Strulovici, B., S. Daniel-Issakani, G. Baxter, J. Knoph, L. Sultzman, H. Cherwinski, J. Nestor Jr., D.R. Webb, and Ransom, J., 1991a, Distinct mechanisms of regulation of protein kinase C∈ by hormones and phorbol diesters, J. Biol. Chem., 256:168–173.
Strulovici, B., Oto, E., Issakani, I., and Baxter G., 1991b, Characterization of PKC isoforms in an established SCLC cell line: regulation of PKCE and its catalytic fragment, J. Cell. Biochem. Suppl., 15B:166.
Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M.M., Bos, J.L., 1988, Genetic alterations during colorectal-tumor development. New Engl. J. Med., 319:525–531 (1988).
Weinberg, R.A., 1989, Positive and negative controls on cell growth, Biochemistry, 28:8263–8269.
Weinstein, I.B., 1988a, The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Twenty-seventh G.H.A. Clowes Memorial Award Lecture, Cancer Research, 38:4135–4143.
Weinstein, I.B., 1988b, Strategies for inhibiting multistage carcinogenesis based on signal transduction pathways, Mutation Research, 202:413–420.
Weinstein, I.B., Borner, C.M., Krauss, R.S., O’Driscoll, K.R., Choi, P.M., Morotomi, M., Hoshina, S., Hsieh, L.L., Tchou-Wong, K.M., Guadagno, S.N., Ueffing, M., and Guillem, J.G., 1990, Pleiotropic effects of protein kinase C and the concept of carcinogenesis as a progressive disorder in signal transduction, In: “The Origins of Human Cancer, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
Weinstein, I.B., 1991a, Mitogenesis is only one factor in carcinogenesis, Science, 251:387–388.
Weinstein, I.B., 1991b, Cancer prevention: recent progress and future opportunities, Cancer Research (Suppl.), 51:5080s-5085s.
Wolfman, A., and Macara, I.G., 1987, Elevated levels of diacyglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts, Nature, 325:359–362.
Woodgett, J.R. and Hunter, T., 1987, Immunological evidence for two physiological forms of protein kinase C, Molec. and Cell. Biol., 7: 85–96.
Young, S., Parker, P.J., Ullrich, A., and Stabel, S., 1987, Down-regulation of protein kinase C is due to an increased rate of degradation, Biochem. J., 244:775–779.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
O’Driscoll, K.R., Kahn, S.M., Borner, C.M., Jiang, W., Weinstein, I.B. (1992). Studies on the Role of Protein Kinase C in Multistage Carcinogenesis and Their Relevance to Risk Extrapolation. In: Zervos, C. (eds) Oncogene and Transgenics Correlates of Cancer Risk Assessments. NATO ASI Series, vol 232. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3056-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3056-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6333-0
Online ISBN: 978-1-4615-3056-5
eBook Packages: Springer Book Archive